Riskpilot← Back to searchSign inGet full accessGunnarsson Läkarkonsult AB
ABActiveOrg 5590749411Ramvägen 9Hospital activities · NACE 8610Est. 20160 employees
Revenue 2025
SEK 259K
-13% vs 2024
EBITDA margin
83.9%
-21% vs 2024
Equity ratio
51.2%
Financial strength
Net profit 2025
SEK 173K
+1% vs 2024
| Revenue | SEK 259K | -13% |
| EBITDA | SEK 217K | -21% |
| Net profit | SEK 173K | +1% |
| Total assets | SEK 464K | +12% |
| Equity | SEK 237K | -3% |
| Employees | 0 | — |
Legal name
Gunnarsson Läkarkonsult AB
Org number
5590749411
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
2 september 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget tillhandahåller legitimerad läkare för tjänster inom hälsa och sjukvård, handel med värdepapper samt därmed förenlig verksamhet.
Address
Ramvägen 9
Email
415gunnarsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 186 | 299 | 259 |
| Staff expenses | — | — | −10 | −3 | −5 |
| EBITDA | −9 | −14 | 158 | 276 | 217 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −9 | −14 | 158 | 276 | 217 |
| Net financials | — | — | 0 | 0 | 1 |
| Profit before tax | −9 | −14 | 128 | 216 | 218 |
| Tax | −0 | — | −22 | −45 | −45 |
| Net profit | −9 | −14 | 107 | 171 | 173 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 56 | 42 | 219 | 412 | 464 |
| Equity | 50 | 36 | 143 | 244 | 237 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 6 | 6 | 47 | 78 | 136 |
| Total debt | 6 | 6 | 47 | 78 | 136 |
EBITDA margin
83.9%
This company
15.8%
Market median
+431% vs market
20212025
Equity ratio
51.2%
This company
38.2%
Market median
+34% vs market
20212025
Return on equity
72.9%
This company
18.4%
Market median
+296% vs market
20212025
Net profit margin
66.9%
This company
8.1%
Market median
+726% vs market
20212025
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20212025
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gunnarsson Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sonja Birgitta Persson | Deputy Board Member | 0 companies |
| Emma Carolina Stenlund | Deputy Board Member | 0 companies |
| Leif Jonas Stenlund | Board of Directors | 0 companies |